90 related articles for article (PubMed ID: 9208809)
1. p53 gene mutations in multiple myeloma.
Owen RG; Davis SA; Randerson J; Rawstron AC; Davies F; Child JA; Jack AS; Morgan GJ
Mol Pathol; 1997 Feb; 50(1):18-20. PubMed ID: 9208809
[TBL] [Abstract][Full Text] [Related]
2. N-ras and p53 gene mutations are very rare events in multiple myeloma.
Yasuga Y; Hirosawa S; Yamamoto K; Tomiyama J; Nagata K; Aokia N
Int J Hematol; 1995 Aug; 62(2):91-7. PubMed ID: 8590778
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma.
Ollikainen H; Syrjänen S; Koskela K; Pelliniemi TT; Pulkki K
Scand J Clin Lab Invest; 1997 Jul; 57(4):281-9. PubMed ID: 9249875
[TBL] [Abstract][Full Text] [Related]
4. Rare occurrence of P53 gene mutations in multiple myeloma.
Preudhomme C; Facon T; Zandecki M; Vanrumbeke M; Laï JL; Nataf E; Loucheux-Lefebvre MH; Kerckaert JP; Fenaux P
Br J Haematol; 1992 Jul; 81(3):440-3. PubMed ID: 1390218
[TBL] [Abstract][Full Text] [Related]
5. Sporadic mutations of the p53 gene in multiple myeloma and no evidence for germline mutations in three familial multiple myeloma pedigrees.
Willems PM; Kuypers AW; Meijerink JP; Holdrinet RS; Mensink EJ
Leukemia; 1993 Jul; 7(7):986-91. PubMed ID: 8321049
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
7. p53 and RAS gene mutations in multiple myeloma.
Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
[TBL] [Abstract][Full Text] [Related]
8. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
9. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
11. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
Zhang X; Fu Y; Liu S; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy.
Neri A; Baldini L; Trecca D; Cro L; Polli E; Maiolo AT
Blood; 1993 Jan; 81(1):128-35. PubMed ID: 8417784
[TBL] [Abstract][Full Text] [Related]
13. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 gene in human myeloma cell lines.
Mazars GR; Portier M; Zhang XG; Jourdan M; Bataille R; Theillet C; Klein B
Oncogene; 1992 May; 7(5):1015-8. PubMed ID: 1373872
[TBL] [Abstract][Full Text] [Related]
15. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
[TBL] [Abstract][Full Text] [Related]
16. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
17. Novel p53 mutation in a malignant tumor secreting vasoactive intestinal peptide.
Lin HJ; French SW; Reichenbach D; Wan YJ; Passaro E; Sawicki MP
Arch Pathol Lab Med; 1997 Feb; 121(2):125-8. PubMed ID: 9126038
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
[TBL] [Abstract][Full Text] [Related]
20. A possible role of the P53 gene deletion as a prognostic factor in multiple myeloma.
Ortega MM; Melo MB; De Souza CA; Lorand-Metze I; Costa FF; Lima CS
Ann Hematol; 2003 Jul; 82(7):405-9. PubMed ID: 12783209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
